|
Site Assessment.
Site selection is critical to ensuring both timely recruitment
and high-quality study data. Together with its consultant experts
in the fields of oncology and neurology and in quality assurance,
we extensively screen and assess sites before including them in
studies.
Furthermore, ERGOMED assesses the qualifications of physicians and nurses, investigator facilities, pharmacy and laboratory services and access to and availability of patients.
|
